Pathway | Aggregated p | CKD RNA-Seq | GSE62792 | GSE37171 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
p | Early | Late | p | Normal | Disease | p | Normal | Disease | ||
Regulation of nuclear SMAD2/3 signaling | 4.13E-06 | 0.012 | FOXO1 | MAX | 0.001 | HNF4A | TCF3 | 0.002 | SMAD2 | FOXO1 |
CD4 T cell receptor signaling | 4.74E-06 | 0.014 | HLA-DPB1 | NFKB1 | 0.001 | HLA-DPA1 | PPP3CC | 0.002 | MAP 3 K7 | CD247 |
TCR signaling in naive CD4+ T cells | 5.93E-06 | 0.018 | PTPRC | CBL | 0.001 | CD3D | IKBKB | 0.002 | RASSF5 | CD247 |
IL2 signaling events mediated by STAT5 | 1.07E-05 | 0.001 | BCL2 | BCL2 | 0.010 | GRB2 | CDK6 | 0.007 | SHC1 | CCND2 |
Angiopoietin receptor Tie2-mediated signaling | 1.82E-05 | 0.001 | FOXO1 | NFKB1 | 0.002 | AKT1 | RAC1 | 0.064 | FOXO1 | MAPK1 |
TRAIL signaling pathway | 1.87E-05 | 0.033 | TNFSF10 | TNFRSF10D | 0.002 | FADD | DAP3 | 0.002 | PIK3CA | MAPK1 |
Signaling events mediated by HDAC Class II | 2.46E-05 | 0.030 | HSP90AA1 | GNB1 | 0.001 | NUP214 | BCOR | 0.006 | GNB1 | RAN |
Neurotrophic factor-mediated Trk receptor signaling | 3.22E-05 | 0.061 | STAT3 | RAP1B | 0.001 | MAPK3 | RAPGEF1 | 0.004 | RHOA | RHOA |
Canonical Wnt signaling pathway Diagram | 3.41E-05 | 0.009 | GSK3B | FZD5 | 0.001 | FRAT1 | DVL3 | 0.029 | WNT11 | EP300 |
Cellular roles of Anthrax toxin | 5.90E-05 | 0.008 | MAP 2 K7 | MAP 2 K1 | 0.001 | MAPK3 | TNF | 0.061 | MAP 2 K4 | MAPK1 |
Methionine and Cysteine metabolism | 6.62E-05 | 0.556 | MTR | MTR | 0.001 | LDHA | AHCY | 0.001 | GOT2 | LDHB |
mRNA splicing | 6.65E-05 | 0.040 | PRPF3 | SNRPA | 0.007 | PRPF3 | PRPF3 | 0.002 | PRPF3 | SNRPA |
Integrin signaling pathway | 6.94E-05 | 0.006 | ARF6 | ILK | 0.001 | ITGAX | ITGB7 | 0.098 | RHOA | RHOA |
Validated nuclear estrogen receptor alpha network | 7.38E-05 | 0.158 | SET | XBP1 | 0.004 | LCOR | HDAC1 | 0.001 | DDX17 | XBP1 |
Wnt signaling pathway | 7.87E-05 | 0.010 | SRCAP | HDAC3 | 0.001 | PRKCD | CSNK2A2 | 0.068 | GNB1 | PPP2R5C |
Arf6 signaling events | 0.00010 | 0.116 | EGFR | GNA14 | 0.002 | ACAP2 | CYTH3 | 0.004 | GNAQ | NCK1 |
Alpha4 beta1 integrin signaling events | 0.00012 | 0.095 | ARF6 | CD14 | 0.006 | CDC42 | CD14 | 0.002 | YWHAZ | ITGA4 |
FGF signaling pathway | 0.00012 | 0.009 | ETS2 | ETS2 | 0.004 | SPI1 | PLCG1 | 0.032 | MAPK1 | MAPK1 |
Syndecan-4-mediated signaling events | 0.00012 | 0.003 | THBS1 | CCL5 | 0.055 | CXCR4 | GIPC1 | 0.007 | ACTN1 | RHOA |
AP-1 transcription factor network | 0.00017 | 0.003 | HLA-A | ETS1 | 0.009 | MMP9 | TRIP6 | 0.063 | CREB1 | CDKN1B |
Signaling events mediated by focal adhesion kinase | 0.00021 | 0.009 | ACTN4 | RAP1B | 0.001 | ROCK2 | ARHGEF7 | 0.233 | RHOA | RHOA |
a6b1 and a6b4 Integrin signaling | 0.00030 | 0.002 | YWHAZ | YWHAG | 0.005 | AKT1 | PIK3R1 | 0.319 | PIK3R1 | YWHAQ |
ATM pathway | 0.00059 | 0.003 | ATM | ABL1 | 0.005 | TOP3A | ATM | 0.472 | TRIM28 | SMC1A |
Validated targets of C-MYC transcriptional repression | 0.00062 | 0.009 | CDKN1B | CEBPD | 0.001 | CREB1 | HDAC1 | 0.833 | ALDH9A1 | EP300 |
Apoptosis signaling pathway | 0.00063 | 0.005 | TNFRSF1A | ATF4 | 0.002 | BIRC3 | LTB | 0.767 | PIK3CA | HSPA5 |
Angiogenesis | 0.00065 | 0.010 | MAPKAPK2 | CRKL | 0.005 | PRKCD | GRAP | 0.161 | GSK3B | RHOA |
Cadherin signaling pathway | 0.00072 | 0.009 | CSNK2A2 | FZD5 | 0.006 | ACTA2 | LEF1 | 0.167 | WNT11 | EGFR |